Home  »  Companies   »  ImmunityBio Inc. (IBRX) Stock Could Soon Reward Pa...

ImmunityBio Inc. (IBRX) Stock Could Soon Reward Patient Investors

ImmunityBio Inc. (NASDAQ: IBRX) is -12.23% lower on its value in year-to-date trading and has touched a low of $2.60 and a high of $7.85 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $4.60 in the last trading session, with the day’s loss setting it -0.15% off its average median price target of $9.00 for the next 12 months. It is also 55.5% off the consensus price target high of $10.00 offered by 2 analysts, but current levels are 44.38% higher than the price target low of $8.00 for the same period.

Currently trading at $4.45, the stock is -5.86% and -17.09% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.29 million and changing -3.26% at the moment leaves the stock -4.57% off its SMA200. IBRX registered -17.90% loss for a year compared to 6-month gain of 5.70%.

5 Undervalued Stocks For 2023

Approximately 544 miles north of Las Vegas lies what's been dubbed "the biggest lithium deposit in the US." One tiny company stands to be the biggest beneficiary because lithium "faces a long-term supply shortage," according to Barron's. This company, however, is sitting on a goldmine opportunity as it plans to produce 30,000 tonnes per annum over the next 3.5 years from this single deposit. Supplying the electric vehicle boom and potentially driving its stock price off the charts. But this is just one of the opportunities we have researched in our free report. The other four companies have just as much potential.

Click here to download your Free Copy…

Sponsored

The stock witnessed a -23.93% loss in the last 1 month and extending the period to 3 months gives it a -16.20%, and is -6.12% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.04% over the week and 8.07% over the month.

ImmunityBio Inc. (IBRX) has around 760 employees, a market worth around $1.75B and $0.60M in sales. Distance from 52-week low is 71.15% and -43.31% from its 52-week high. The company has generated returns on investments over the last 12 months (-90.10%).

ImmunityBio Inc. (IBRX) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for ImmunityBio Inc. (IBRX) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

ImmunityBio Inc. is expected to release its quarterly report on 05/11/2023.The EPS is expected to shrink by -51.40% this year.

ImmunityBio Inc. (IBRX) Top Institutional Holders

The shares outstanding are 400.06M, and float is at 83.44M with Short Float at 26.88%.

ImmunityBio Inc. (IBRX) Insider Activity

A total of 4 insider transactions have happened at ImmunityBio Inc. (IBRX) in the last six months, with sales accounting for 1 and purchases happening 3 times.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts